Ignite Creation Date:
2025-12-25 @ 3:46 AM
Ignite Modification Date:
2026-06-16 @ 4:11 PM
Study NCT ID:
NCT00770302
Status:
COMPLETED
Last Update Posted:
2009-07-09
First Post:
2008-10-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Assess Pharmacokinetics, Safety and Tolerability in Healthy Chinese Volunteers After Oral Doses of Saxagliptin
Sponsor:
AstraZeneca
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D1680C00004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Peter Öhman, MD, PhD, Medical Science Director
Old Organization:
AstraZeneca Pharmaceuticals
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |